Logo for Sesen Bio Inc

Sesen Bio Investor Relations Material

Latest events

Logo for Sesen Bio Inc

Investor Update

Sesen Bio
Logo for Sesen Bio

Q4 2022

28 Feb, 2023
Logo for Sesen Bio

Investor Update

21 Feb, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Sesen Bio Inc

Access all reports
Sesen Bio is developing fusion protein therapeutics for the treatment of patients with cancer based on a proprietary platform technology. This technology utilizes proprietary ligand design, a data-driven computational approach to molecular modeling, and molecular engineering to develop a library of novel fusion protein therapeutics. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.